FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Goss Michael L

 2. Date of Event Requiring Statement (MM/DD/YYYY)
8/30/2019 

 3. Issuer Name and Ticker or Trading Symbol

Care.com Inc [CRCM]

(Last)        (First)        (Middle)

C/O CARE.COM, INC., 77 FOURTH AVENUE, 5TH FLOOR

 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Acting Chief Financial Officer /

(Street)

WALTHAM, MA 02451      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.001 par value 3161 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (1) (1)Common Stock 1399  (2)D  
Restricted Stock Units  (3) (3)Common Stock 2114  (2)D  
Restricted Stock Units  (4) (4)Common Stock 915  (2)D  
Restricted Stock Units  (5) (5)Common Stock 2889  (2)D  
Restricted Stock Units  (6) (6)Common Stock 634  (2)D  
Restricted Stock Units  (7) (7)Common Stock 4020  (2)D  
Options (Right to Buy)  (8) (8)Common Stock 5832 $6.70 D  
Options (Right to Buy)  (9) (9)Common Stock 6334 $12.01 D  
Explanation of Responses:
(1) The restricted stock units will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(2) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
(3) The restricted stock units will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(4) The restricted stock units will vest as to 33.33% of the original grant on February 26, 2018 and as to an additional 16.67% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(5) The restricted stock units will vest as to 6.25% of the original grant on June 9, 2018 and at the end of each successive three month period thereafter until March 9, 2022, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(6) The restricted stock units will vest as to 50% of the original grant on March 9, 2019 and as to an additional 12.5% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(7) The restricted stock units will vest as to 6.25% of the original grant on June 9, 2019 and at the end of each successive three month period thereafter until March 9, 2023, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
(8) The options will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 10, 2026.
(9) The options will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 15, 2027.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Goss Michael L
C/O CARE.COM, INC.
77 FOURTH AVENUE, 5TH FLOOR
WALTHAM, MA 02451

Acting Chief Financial Officer
Signatures
/s/ Melanie Goins, as Attorney-in-Fact for Michael Goss9/4/2019
**Signature of Reporting PersonDate
Care com (NYSE:CRCM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Care com.
Care com (NYSE:CRCM)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Care com.